What is Syntr Health Technologies?
Syntr Health Technologies, established in 2018 and headquartered in Irvine, California, is a medical device company focused on accelerating adipose tissue processing at the point of care. Founded by three engineers, the company emerged following a successful NIH Phase I SBIR grant. Syntr aims to become a market leader by offering automated solutions that reduce patient recovery times and enhance quality of life. The company operates from University Lab Partners, a prominent wet lab incubator in Orange County.
How much funding has Syntr Health Technologies raised?
Syntr Health Technologies has raised a total of $2.2M across 1 funding round:
Angel/Seed
$2.2M
Angel/Seed (2021): $2.2M, investors not publicly disclosed
What's next for Syntr Health Technologies?
The recent major strategic investment, coupled with the overall enterprise-level funding context, suggests Syntr Health Technologies is poised for significant scaling and market penetration. This capital infusion will likely fuel further research and development, expand manufacturing capabilities, and support broader commercialization efforts. The company's focus on improving patient outcomes through innovative technology positions it for substantial growth in the healthcare industry.
See full Syntr Health Technologies company page
